CSPC Pharmaceutical Group Limited
CHJTF
$1.28
$0.0756.25%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 9.71% | -1.71% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.71% | -1.71% | |||
| Cost of Revenue | 13.66% | -3.44% | |||
| Gross Profit | 7.88% | -0.88% | |||
| SG&A Expenses | -16.48% | 6.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.11% | 0.48% | |||
| Operating Income | 95.51% | -15.11% | |||
| Income Before Tax | 113.18% | -12.20% | |||
| Income Tax Expenses | 0.25% | 53.22% | |||
| Earnings from Continuing Operations | 175.79% | -29.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -218.91% | 120.11% | |||
| Net Income | 165.76% | -27.76% | |||
| EBIT | 95.51% | -15.11% | |||
| EBITDA | 70.24% | -8.45% | |||
| EPS Basic | 168.18% | -26.67% | |||
| Normalized Basic EPS | 79.73% | 12.12% | |||
| EPS Diluted | 168.18% | -26.67% | |||
| Normalized Diluted EPS | 79.73% | 12.12% | |||
| Average Basic Shares Outstanding | -1.02% | -1.22% | |||
| Average Diluted Shares Outstanding | -1.02% | -1.22% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||